Should you buy Paragon 28 stock?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Paragon 28 in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Paragon 28 stock. View analyst ratings for Paragon 28 or view top-rated stocks.
What price target do analysts set for Paragon 28 (FNA)?
What price target have analysts set for FNA? 3 analysts have issued 12-month target prices for Paragon 28's stock. Their forecasts range from $25.00 to $30.00. On average, they anticipate Paragon 28's stock price to reach $28.00 in the next year. This suggests a possible upside of 58.2% from the stock's current price.
Is Paragon technologies (pgnt) a holding company?
EASTON, PA / ACCESSWIRE / May 13, 2021 / Paragon Technologies, Inc. (OTC Pink:PGNT), a holding company, announced its results for the three months ended March 31, 2021, on May 13, 2021. © 2022 Yahoo. All rights reserved.
Who is the underwriter for Paragon 28?
BofA Securities and Piper Sandler served as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers. What is Paragon 28's stock symbol? Paragon 28 trades on the New York Stock Exchange (NYSE) under the ticker symbol "FNA."
Is Paragon publicly traded?
(NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before ...
Is KD stock a good buy?
An understandably terrible impression by the public market and incredibly bad trading dynamics have contributed to a very good risk-reward tradeoff. I expect KD to solidly outperform the market over a 3-year period and recommend buying at the current level.
Does KD pay a dividend?
Kyndryl Holdings (NYSE: KD) does not pay a dividend.
Is Kyndryl undervalued?
As mentioned earlier, at the current price the company is undervalued, based on last twelve months financials, by 20%. But if we consider the transformation the company is going through the undervaluation is even bigger.
What is Paragon 28?
What Type Of Shareholders Make Up Paragon 28, Inc.'s (NYSE:FNA) Share Registry?
Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. All of the shares are being offered and sold by PARAGON. PARAGON's common stock is e
What is the rating of Paragon 28?
If you want to know who really controls Paragon 28, Inc. ( NYSE:FNA ), then you'll have to look at the makeup of its...
What is the official website for Paragon 28?
Paragon 28 has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
When did Paragon 28's quiet period end?
The official website for Paragon 28 is www.paragon28.com.
Where is Paragon 28 located?
Paragon 28's quiet period expired on Wednesday, November 24th. Paragon 28 had issued 7,812,500 shares in its IPO on October 15th. The total size of the offering was $125,000,000 based on an initial share price of $16.00. During the company's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
Does Paragon 28 pay dividends?
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Recently Viewed Tickers
Paragon 28 does not currently pay a dividend.
Paragon 28 Inc
Visit a quote page and your recently viewed tickers will be displayed here.
2.5 Analyst's Opinion
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.
Is Paragon ID a buy right now?
Paragon ID has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
What price target have analysts set for PAGDF?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Paragon ID in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Paragon ID stock. View analyst ratings for Paragon ID or view top-rated stocks.
Who are some of Paragon ID's key competitors?
1 brokerages have issued twelve-month price targets for Paragon ID's shares. Their forecasts range from $40.00 to $40.00. On average, they anticipate Paragon ID's share price to reach $40.00 in the next year.
How do I buy shares of Paragon ID?
Some companies that are related to Paragon ID include AMS (AUKUF), Bluechiip (BCT), BrainChip (BRN), BrainChip (BRCHF), Dynex Power (DNXWF), Infineon Technologies (IFXA), Infineon Technologies (IFNNF), K2 Energy (KTE), MediaTek (MDTKF), Melexis (MLXSF), Nordic Semiconductor ASA (NRSDY), Renesas Electronics (RNECY), Renesas Electronics (RNECF), Semiconductor Manufacturing International (SIUIF) and Silex Systems (SLX). View all of PAGDF's competitors..
What is Paragon ID's stock price today?
Shares of PAGDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Where are Paragon ID's headquarters?
One share of PAGDF stock can currently be purchased for approximately $33.84.
